Sofinnova Investments, Inc. Dyne Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 1,625,703 shares of DYN stock, worth $53.7 Million. This represents 3.18% of its overall portfolio holdings.
Number of Shares
1,625,703
Previous 1,936,650
16.06%
Holding current value
$53.7 Million
Previous $55 Million
4.35%
% of portfolio
3.18%
Previous 3.2%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
201Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$265 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$259 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$244 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$211 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$200 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.71B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...